Pembrolizumab, 50 mg
Order number: 1374853-91-4
Part number: AC100041212
£ 3981.29*
*Prices without VAT and shipping costs£ 4777.55*
*incl. VAT, plus shipping costsPrice Breakdown
1
6
24
Pembrolizumab is a technically defined substance, characterized as an IgG4 monoclonal antibody. Its molecular formula is C85H170N4OS, with a molecular weight of 1296.4. This compound belongs to the immunoglobulin superfamily, specifically targeting programmed death-1 (PD-1) proteins, thereby modulating immune responses. Handling requires adherence to standard laboratory practices for biomolecules, including Pembrolizumab demonstrates high affinity and specificity towards PD-1, making it a key therapeutic agent in cancer treatment. It has been approved for the management of various types of malignancies, such as melanoma and non-small cell lung cancer.
- CAS Number: 1374853-91-4
- Molecular Weight: 1296.4
- Molecular Formula: C85H170N4OS
- Exact Mass: 1295.30953723
| Name | Value | |
|---|---|---|
| WGK | : | 1 |
| CAS No. | : | 1374853-91-4 |
| Empirical formula | : | C6534H10004N1716O2036S46 |
Write a Review
Reviews
SPEZ-2ACE-EN
SDB-2ACE-AT-DE
